Company profile
Bright Green Corporation
PNK: BGXXQ · Healthcare · Medical - Pharmaceuticals
#1161 of 1,417 Healthcare companies by revenue
EA Score
——FH —DQ 11GM —SS 13
v0.1 · 25/100 weight · pillars only
↑ balance-sheet leverage, Altman-Z · ↓ Piotroski F, listing tenure
Methodology →Revenue TTM
$87.2k
Rev growth YoY (TTM)
-81.7%
Net income (FY)
-$13.1M
Employees
5
as of 2026-08-28
Market cap
$38.2k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02023
Net income-$13.1M-$13.1M2023
Operating income-$8.9M-$8.9M2023
Total assets$17.4M$17.4M2023
Liabilities$6.4M$6.4M2023
Equity$11.0M$11.0M2023
Revenue trend
FY2022 – FY2023 · USD
FY22
FY22
FY23
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Bright Green Corporation’s revenue?
Bright Green Corporation booked $0 in FY2023 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
SOAFEE, Inc.——Nunzia Pharmaceutical Company——Petlife Pharmaceuticals, Inc.——Wellness Matrix Group, Inc.——THC Therapeutics, Inc.——Health Advance Inc.——Neighbors
Broward →Key facts
CEOLynn Stockwell
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersFort Lauderdale, FL
ExchangePNK: BGXXQ
Employees5
IPO date2025-02-18
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.